Abstract
Emergence delirium (ED) is a common mental complication during recovery from anesthesia. However, studies on the effects of esketamine, an intravenous anesthetic for pediatrics, on ED are still lacking. This study aimed to investigate the effects of a single-dose of esketamine during anesthesia induction on ED after minor surgery in preschool children. A total of 230 children (aged 2–7 years) completed the study. The exposed group (0.46 mg kg−1: average dose of esketamine) was associated with an increased incidence of ED and a higher maximum Pediatric Anesthesia Emergence Delirium score than the non-exposed group. The length of post-anesthesia care unit stay was longer in the exposed group than the non-exposed group. In contrast, extubation time, face, legs, activity, cry, and consolability (FLACC) scores, and the proportions of rescue analgesics were comparable between the two groups. Furthermore, five factors, including preoperative anxiety scores, sevoflurane and propofol compared with sevoflurane alone for anesthesia maintenance, dezocine for postoperative analgesia, FLACC scores, and esketamine exposure, were associated with ED. In conclusion, a near-anesthetic single-dose of esketamine for anesthesia induction may increase the incidence of ED in preschool children after minor surgery. The use of esketamine in preschool children for minor surgery should be noticed during clinical practice.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study were included in the published article. Further inquiries about the datasets can be directed to the corresponding author on reasonable request.
References
Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG, Nomenclature Consensus Working G (2018) Recommendations for the nomenclature of cognitive change associated with Anaesthesia and surgery-2018. Br J Anaesth 121(5):1005–1012. https://doi.org/10.1016/j.bja.2017.11.087
Urits I, Peck J, Giacomazzi S, Patel R, Wolf J, Mathew D, Schwartz R, Kassem H, Urman RD, Kaye AD, Viswanath O (2020) Emergence delirium in perioperative pediatric care: a review of current evidence and new directions. Adv Ther 37 (5):1897–1909. https://doi.org/10.1007/s12325-020-01317-x
Dahmani S, Delivet H, Hilly J (2014) Emergence delirium in children: an update. Curr Opin Anaesthesiol 27(3):309–315. https://doi.org/10.1097/ACO.0000000000000076
Martini DR (2005) Commentary: the diagnosis of delirium in pediatric patients. J Am Acad Child Adolesc Psychiatry 44(4):395–398. https://doi.org/10.1097/01.chi.0000153716.52154.cf
Mason KP (2017) Paediatric emergence delirium: a comprehensive review and interpretation of the literature. Br J Anaesth 118(3):335–343. https://doi.org/10.1093/bja/aew477
Dahmani S, Stany I, Brasher C, Lejeune C, Bruneau B, Wood C, Nivoche Y, Constant I, Murat I (2010) Pharmacological prevention of sevoflurane- and desflurane-related emergence agitation in children: a meta-analysis of published studies. Br J Anaesth 104(2):216–223. https://doi.org/10.1093/bja/aep376
Kain ZN, Caldwell-Andrews AA, Maranets I, McClain B, Gaal D, Mayes LC, Feng R, Zhang H (2004) Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors. Anesth Analg 99(6):1648–1654. https://doi.org/10.1213/01.ANE.0000136471.36680.97
White PF, Schuttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ (1985) Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth 57(2):197–203. https://doi.org/10.1093/bja/57.2.197
Himmelseher S, Pfenninger E (1998) The clinical use of S-(+)-ketamine—a determination of its place. Anasthesiol Intensivmed Notfallmed Schmerzther 33(12):764–770. https://doi.org/10.1055/s-2007-994851
Wang J, Huang J, Yang S, Cui C, Ye L, Wang SY, Yang GP, Pei Q (2019) Pharmacokinetics and safety of esketamine in Chinese patients undergoing painless gastroscopy in comparison with ketamine: a randomized, open-label clinical study. Drug Des Devel Ther 13:4135–4144. https://doi.org/10.2147/DDDT.S224553
Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP (1998) Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 88(1):82–88. https://doi.org/10.1097/00000542-199801000-00015
Pfenninger EG, Durieux ME, Himmelseher S (2002) Cognitive impairment after small-dose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteers. Anesthesiology 96(2):357–366. https://doi.org/10.1097/00000542-200202000-00022
Jeong WJ, Kim WY, Moon MG, Min DJ, Lee YS, Kim JH, Park YC (2012) The effect of ketamine on the separation anxiety and emergence agitation in children undergoing brief ophthalmic surgery under desflurane general anesthesia. Korean J Anesthesiol 63(3):203–208. https://doi.org/10.4097/kjae.2012.63.3.203
Lee YS, Kim WY, Choi JH, Son JH, Kim JH, Park YC (2010) The effect of ketamine on the incidence of emergence agitation in children undergoing tonsillectomy and adenoidectomy under sevoflurane general anesthesia. Korean J Anesthesiol 58(5):440–445. https://doi.org/10.4097/kjae.2010.58.5.440
Schmitz A, Weiss M, Kellenberger C, O’Gorman Tuura R, Klaghofer R, Scheer I, Makki M, Sabandal C, Buehler PK (2018) Sedation for magnetic resonance imaging using propofol with or without ketamine at induction in pediatrics—a prospective randomized double-blinded study. Paediatr Anaesth 28(3):264–274. https://doi.org/10.1111/pan.13315
Abitagaoglu S, Koksal C, Alagoz S, Karip CS, Ari DE (2021) Effect of ketamine on emergence agitation following septoplasty: a randomized clinical trial. Braz J Anesthesiol 71(4):381–386. https://doi.org/10.1016/j.bjane.2020.12.027
Ringblom J, Wahlin I, Proczkowska M (2018) A psychometric evaluation of the Pediatric Anesthesia Emergence Delirium scale. Paediatr Anaesth 28(4):332–337. https://doi.org/10.1111/pan.13348
Sikich N, Lerman J (2004) Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology 100(5):1138–1145. https://doi.org/10.1097/00000542-200405000-00015
Hauber JA, Davis PJ, Bendel LP, Martyn SV, McCarthy DL, Evans MC, Cladis FP, Cunningham S, Lang RS, Campbell NF, Tuchman JB, Young MC (2015) Dexmedetomidine as a rapid bolus for treatment and prophylactic prevention of emergence agitation in anesthetized children. Anesth Analg 121(5):1308–1315. https://doi.org/10.1213/ANE.0000000000000931
Shi M, Miao S, Gu T, Wang D, Zhang H, Liu J (2019) Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: a double-blind, randomized trial. Drug Des Devel Ther 13:897–905. https://doi.org/10.2147/DDDT.S196075
Crellin DJ, Harrison D, Santamaria N, Babl FE (2015) Systematic review of the Face, Legs, Activity, Cry and Consolability scale for assessing pain in infants and children: Is it reliable, valid, and feasible for use? Pain 156(11):2132–2151. https://doi.org/10.1097/j.pain.0000000000000305
Lu X, Tang L, Lan H, Li C, Lin H (2021) A comparison of intranasal dexmedetomidine, esketamine or a dexmedetomidine-esketamine combination for induction of anaesthesia in children: a randomized controlled double-blind trial. Front Pharmacol 12:808930. https://doi.org/10.3389/fphar.2021.808930
Donahue PJ, Dineen PS (1992) Emergence delirium following oral ketamine. Anesthesiology 77(3):604–605. https://doi.org/10.1097/00000542-199209000-00036
Short B, Fong J, Galvez V, Shelker W, Loo CK (2018) Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry 5(1):65–78. https://doi.org/10.1016/S2215-0366(17)30272-9
Clements JA, Nimmo WS, Grant IS (1982) Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci 71(5):539–542. https://doi.org/10.1002/jps.2600710516
Clements JA, Nimmo WS (1981) Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 53(1):27–30. https://doi.org/10.1093/bja/53.1.27
Zarate CA Jr, Brutsche N, Laje G, Luckenbaugh DA, Venkata SL, Ramamoorthy A, Moaddel R, Wainer IW (2012) Relationship of ketamine’s plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry 72(4):331–338. https://doi.org/10.1016/j.biopsych.2012.03.004
Idvall J, Ahlgren I, Aronsen KR, Stenberg P (1979) Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth 51(12):1167–1173. https://doi.org/10.1093/bja/51.12.1167
Grant IS, Nimmo WS, McNicol LR, Clements JA (1983) Ketamine disposition in children and adults. Br J Anaesth 55(11):1107–1111. https://doi.org/10.1093/bja/55.11.1107
Little B, Chang T, Chucot L, Dill WA, Enrile LL, Glazko AJ, Jassani M, Kretchmer H, Sweet AY (1972) Study of ketamine as an obstetric anesthetic agent. Am J Obstet Gynecol 113(2):247–260. https://doi.org/10.1016/0002-9378(72)90774-0
Reich DL, Silvay G (1989) Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 36(2):186–197. https://doi.org/10.1007/BF03011442
Bali A, Dang AK, Gonzalez DA, Kumar R, Asif S (2022) Clinical uses of ketamine in children: a narrative review. Cureus 14 (7):e27065. https://doi.org/10.7759/cureus.27065
Mathisen LC, Skjelbred P, Skoglund LA, Oye I (1995) Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 61(2):215–220. https://doi.org/10.1016/0304-3959(94)00170-J
Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate CA Jr, Gould TD (2018) Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev 70(3):621–660. https://doi.org/10.1124/pr.117.015198
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, Lee Y, Lui LMW, Mansur RB, Papakostas GI, Subramaniapillai M, Thase M, Vieta E, Young AH, Zarate CA Jr, Stahl S (2021) Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry 178(5):383–399. https://doi.org/10.1176/appi.ajp.2020.20081251
Nishimura M, Sato K, Okada T, Yoshiya I, Schloss P, Shimada S, Tohyama M (1998) Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 88(3):768–774. https://doi.org/10.1097/00000542-199803000-00029
Ebert TJ, Muzi M (1993) Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers. A comparison with isoflurane. Anesthesiology 79(3):444–453. https://doi.org/10.1097/00000542-199309000-00006
Singh JB, Fedgchin M, Daly E, Xi L, Melman C, De Bruecker G, Tadic A, Sienaert P, Wiegand F, Manji H, Drevets WC, Van Nueten L (2016) Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study. Biol Psychiatry 80(6):424–431. https://doi.org/10.1016/j.biopsych.2015.10.018
Wang X, Lin C, Lan L, Liu J (2021) Perioperative intravenous S-ketamine for acute postoperative pain in adults: a systematic review and meta-analysis. J Clin Anesth 68:110071. https://doi.org/10.1016/j.jclinane.2020.110071
Ng KT, Sarode D, Lai YS, Teoh WY, Wang CY (2019) The effect of ketamine on emergence agitation in children: a systematic review and meta-analysis. Paediatr Anaesth 29(12):1163–1172. https://doi.org/10.1111/pan.13752
Moore AD, Anghelescu DL (2017) Emergence delirium in pediatric anesthesia. Paediatr Drugs 19(1):11–20. https://doi.org/10.1007/s40272-016-0201-5
An LJ, Zhang Y, Su Z, Zhang XL, Liu HL, Zhang ZJ, Hu JL, Li ST (2017) A single dose of dezocine suppresses emergence agitation in preschool children anesthetized with sevoflurane-remifentanil. BMC Anesthesiol 17(1):154. https://doi.org/10.1186/s12871-017-0446-8
Xia Y, Sun Y, Liu J (2021) Effects of dezocine on PAED scale and Ramsay sedation scores in patients undergoing NUSS procedure. Am J Transl Res 13(5):5468–5475
Ye RR, Jiang S, Xu X, Lu Y, Wang YJ, Liu JG (2022) Dezocine as a potent analgesic: overview of its pharmacological characterization. Acta Pharmacol Sin 43(7):1646–1657. https://doi.org/10.1038/s41401-021-00790-6
Uezono S, Goto T, Terui K, Ichinose F, Ishguro Y, Nakata Y, Morita S (2000) Emergence agitation after sevoflurane versus propofol in pediatric patients. Anesth Analg 91(3):563–566. https://doi.org/10.1097/00000539-200009000-00012
Chu Q, Zhu K, Bai Y, Shang H, Zhang D, Zhao M, Zheng P, Jin X (2021) A single low dose of dexmedetomidine efficiently attenuates esketamine-induced overactive behaviors and neuronal hyperactivities in mice. Front Hum Neurosci 15:735569. https://doi.org/10.3389/fnhum.2021.735569
Chu Q, Mao M, Bai Y, Sun L, Zhang D, Zheng P, Jin X (2022) Midazolam attenuates esketamine-induced overactive behaviors in mice before the sedation, but not during the recovery. Front Vet Sci 9:829747. https://doi.org/10.3389/fvets.2022.829747
Fang XZ, Gao J, Ge YL, Zhou LJ, Zhang Y (2016) Network meta-analysis on the efficacy of dexmedetomidine, midazolam, ketamine, propofol, and fentanyl for the prevention of sevoflurane-related emergence agitation in children. Am J Ther 23(4):e1032–e1042. https://doi.org/10.1097/MJT.0000000000000321
Zhang J, Ma L, Wan X, Shan J, Qu Y, Hashimoto K (2021) (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation. Psychopharmacology (Berl) 238(10):2743–2753. https://doi.org/10.1007/s00213-021-05889-6
Wei Y, Chang L, Hashimoto K (2022) Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor. Mol Psychiatry 27(1):559–573. https://doi.org/10.1038/s41380-021-01121-1
Zhang JC, Yao W, Hashimoto K (2022) Arketamine, a new rapid-acting antidepressant: a historical review and future directions. Neuropharmacology 218:109219. https://doi.org/10.1016/j.neuropharm.2022.109219
Hashimoto K (2023) Arketamine for cognitive impairment in psychiatric disorders. Eur Arch Psychiatry Clin Neurosci 14:1–13. https://doi.org/10.1007/s00406-023-01570-5
Acknowledgements
The authors would like to acknowledge all of the staff who assisted this study.
Funding
This work was supported by the grants from the National Natural Science Foundation of China (Nos. 82171189, 82001157, 81971020).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
Dr. Hashimoto is the inventor of filed patent applications on “The use of R-Ketamine in the treatment of psychiatric diseases”, “(S)-norketamine and salt thereof as pharmaceutical”, “R-Ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder”, “Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases”, and “R-Ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder” by the Chiba University. Dr. Hashimoto has also received speakers’ honoraria, consultant fee, or research support from Abbott, Boehringer-Ingelheim, Daiichi-Sankyo, Meiji Seika Pharma, Seikagaku Corporation, Dainippon-Sumitomo, Taisho, Otsuka, Murakami Farm and Perception Neuroscience. The other authors have no competing interests.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, S., Yang, JJ., Zhang, Y. et al. Risk of esketamine anesthesia on the emergence delirium in preschool children after minor surgery: a prospective observational clinical study. Eur Arch Psychiatry Clin Neurosci (2023). https://doi.org/10.1007/s00406-023-01611-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00406-023-01611-z